4
Changes in Ownership
IONIS PHARMACEUTICALS INC Filed Acc 0000874015-23-000091
EVP, Chief Development Officer sold 1,920 shares at $40.66 ($78,070)
- EVP, Chief Development Officer acquired 3,822 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Geary Richard S · EVP, Chief Development Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2023-02-03 | Grant or award : show line 1 in the form | +3,822 | 74,305 | D | ||
| 2023-02-06 | Sale : show line 2 in the form | −1,920 | $40.66 | $78,070 | 72,385 | D |
| Open-market sales · 1,920 sh · avg $40.66 · $78,070 | ||||||
Loading xslF345X03/edgardoc.xml…